Importantly, in contrast to other genetic models of enhanced cardiomyocyte proliferative growth17,20, the morphological changes observed here during development in Dusp5–/– mice do not impact negatively on stroke volume, body weight or survival. The gene discussed is DUSP5; the disease is stroke disorder.